Press Releases
PIA Vietnam to return in March 2011 with broader focus
The next edition of PIA Vietnam, a premier trade event focused on process engineering and instrumentation as well as laboratory and scientific equipment, will be...
Press Releases
Allan Mackintosh, PMAP Performance Coach, Grunenthal, on the evolving KAM approach
Allan Mackintosh, PMAP Performance Coach, Gruenthal believes that the KAM approach is where we will see most change within the pharma industry over the next...
Press Releases
Roche personalized investigational medicine shows survival benefit in advanced skin cancer
Roche announced that BRIM3, a Phase III clinical study of RG7204 (PLX4032), met its co-primary endpoints showing a significant survival benefit in people with previously...
Press Releases
ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients
ARIAD Pharmaceuticals, Inc. announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared to...
Press Releases
Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes
An investigational drug-eluting stent (DES) from Cook Medical showed sustained primary patency at two years compared to data collected at one year in the device’s...
Press Releases
Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments
Boehringer Ingelheim and Eli Lilly and Company announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and...
Press Releases
Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab
Sandoz announced today that it has begun a phase II clinical trial in patients for biosimilar rituximab (Roche's Rituxan® / Mabthera), a leading monoclonal antibody...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.